ID
45135
Descrizione
Principal Investigator: Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA MeSH: Prostatic Neoplasms https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330 Seven primary prostate cancers and their paired normal counterparts were DNA-sequenced on a massively parallel sequencing platform. This approach was taken to investigate the genomes for mutations and genomic alterations that would be undetectable by lower-resolution methods. As result, tumors containing chains of balanced rearrangements that occurred within or adjacent to known cancer genes were discovered.
collegamento
https://www.ncbi.nlm.nih.gov/projects/gap/cgi-bin/study.cgi?study_id=phs000330
Keywords
versioni (3)
- 08/10/22 08/10/22 - Adrian Schulz
- 12/10/22 12/10/22 - Adrian Schulz
- 12/10/22 12/10/22 - Adrian Schulz
Titolare del copyright
Mark A. Rubin, MD, Weill Cornell Medical College, New York, NY, USA
Caricato su
8 ottobre 2022
DOI
Per favore, per richiedere un accesso.
Licenza
Creative Commons BY 4.0
Commenti del modello :
Puoi commentare il modello dati qui. Tramite i fumetti nei gruppi di articoli e articoli è possibile aggiungere commenti a quelli in modo specifico.
Commenti del gruppo di articoli per :
Commenti dell'articolo per :
Per scaricare i modelli di dati devi essere registrato. Per favore accesso o registrati GRATIS.
dbGaP phs000330 The Genomic Complexity of Primary Human Prostate Cancer
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
Similar models
Eligibility Criteria
- StudyEvent: SEV1
- Eligibility Criteria
- Subject ID, subject sources, consent form, and affection status of participants affected with prostate cancer.
- Sample ID, subject ID, and sample sources of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor sample characteristics, and demography of participants affected with prostate cancer.
- Prostate tumor characteristics, tumor and normal blood sample characteristics, and subject ID of participants affected with prostate cancer.
C1512693 (UMLS CUI [1,2])